Maryam Tahvildari

Maryam Tahvildari

Harvard University - Cambridge / United States
Medical and Health Sciences / Ophthalmology
AD Scientific Index ID: 1398917
person_outline Maryam Tahvildari's MOST POPULAR ARTICLES
1-) Low-dose IL-2 therapy in transplantation, autoimmunity, and inflammatory diseasesM Tahvildari, R DanaThe Journal of Immunology 203 (11), 2749-2755, 2019762019
2-) In vivo expansion of regulatory T cells by low-dose interleukin-2 treatment increases allograft survival in corneal transplantationM Tahvildari, M Omoto, Y Chen, P Emami-Naeini, T Inomata, TH Dohlman, ...Transplantation 100 (3), 525, 2016762016
3-) Graves\' ophthalmopathy and gene polymorphisms in interleukin‐1α, interleukin‐1β, interleukin‐1 receptor and interleukin‐1 receptor antagonistO Khalilzadeh, M Anvari, A Esteghamati, M Mahmoudi, M Tahvildari, ...Clinical & Experimental Ophthalmology 37 (6), 614-619, 2009492009
4-) Association of CTLA-4 gene polymorphism with Graves\' disease and ophthalmopathy in Iranian patientsA Esteghamati, O Khalilzadeh, Z Mobarra, M Anvari, M Tahvildari, ...European Journal of Internal Medicine 20 (4), 424-428, 2009472009
5-) Prevention of corneal neovascularization: comparison of different doses of subconjunctival bevacizumab with its topical form in experimental ratsMN Hashemian, H Z-Mehrjardi, S Moghimi, M Tahvildari, H Mojazi-AmiriOphthalmic research 46 (1), 50-54, 2011462011